Interferon-Α Immunotherapy, Combined with Praziquantel Downregulates VEGF Gene Expression, Causing Regression of Hepatic Fibrosis in Chronic Schistosoma Mansoni Experimental Infection

Pentoxifylline and/or praziquantel reduce murine schistosomiasis mansoni histopathology via amelioration of liver functions

THE ANTIFIBROTIC POTENTIAL OF RESVERATROL IN SCHISTOSOMA MANSONI -INFECTED MICE

BLOCKADE OF PGE2, PGD2 RECEPTORS CONFERS PROTECTION AGAINST PREPATENT SCHISTOSOMIASIS MANSONI IN MICE

ANTI-SCHISTOSOMAL AND ANTIFIBROTIC EFFECTS OF RESVERATROL LOADED ON NIOSOMES IN MURINE SCHISTOSOMIASIS MANSONI

TAMOXIFEN VERSUS PRAZIQUANTEL IN TREATING SCHISTOSOMIASIS MANSONI IN EXPERIMENTAL INFECTED ALBINO MICE

Effect of Praziquantel, Allicin, and Curcumin on The Histology of Liver, Spleen, and Kidney of Schistosoma mansoni Infected Mice

AMELIORATIVE EFFECT OF CALOTROPIS PROCERA AND/OR PRAZIQUANTEL ON SCHISTOSOMA MANSONI INFECTED MICE

EFFICACY OF PENTOXIFYLLINE AS AN ANTIFIBROTIC DRUG IN EXPERIMENTAL MURINE SCHISTOSOMAL HEPATIC FIBROSIS

SYNERGY BETWEEN BETA-1, 3-GLUCAN AND PRAZIQUANTEL IN THE TREATMENT OF EXPERIMENTAL CHRONIC SCHISTOSOMIASIS MANSONI